Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sky Century InvestmentSKYI -16.67%29 Days Payable is 34.22 as of May. 2026, which is 86% below its 10-year median of 253.00. GuruFocus rates SKYI with a GF Score™ of 29/100. The stock has 6 warning signs investors should review. Among 923 Drug Manufacturers companies, Sky Century Investment ranks better than 71.51% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's Days Payable distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sky Century Investment's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sky Century Investment (SKYI) has a Days Payable of 34.22 as of May. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sky Century Investment and its competitors. This is 86% below median its historical median of 253.00. Over the past decade, Sky Century Investment's Days Payable has ranged from 135.93 to 302.43. According to the industry distribution chart, Sky Century Investment ranks #263 out of 923 companies in the Drug Manufacturers industry, placing it in the top 28.5%.
Is Sky Century Investment's Days Payable too high?
Sky Century Investment's current Days Payable of 34.22 is 86% below median its 10-year median of 253.00. Over the past 10 years, this metric has ranged from a low of 135.93 to a high of 302.43. The Drug Manufacturers industry median Days Payable is 88.75. Sky Century Investment's value of 34.22 is 61.4% below this industry median. Based on the distribution chart, Sky Century Investment ranks #263 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sky Century Investment has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's Days Payable compare to SHPH and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #263 out of 923 companies for Days Payable. This puts Sky Century Investment in the upper half of its industry. The industry median Days Payable is 88.75. Sky Century Investment's value of 34.22 is 61.4% below this benchmark. Historically, Sky Century Investment's own Days Payable has ranged from 135.93 to 302.43 over the past decade. While the company's 10-year median is 253.00 vs. the industry median of 88.75, Sky Century Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.75, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current Days Payable of 34.22 is 61.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sky Century Investment and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current Days Payable is 34.22, which is 86% below median its own 10-year median of 253.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current Days Payable of 34.22. The current Days Payable is 34.22, which is 86% below median its 10-year median of 253.00 and 61.4% below the Drug Manufacturers industry median of 88.75. Sky Century Investment's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current Days Payable is 34.22 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
29GF Score
Get the complete analysis for SKYI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
